Bye, A. P., Kriek, N., Sage, T., Rawlings, S. J., Prodger, C., Kesavan, M., Lees, C., Booth, S., Cowen, L. G., Shefferd, K., Desborough, M. J., Gibbins, J. M. and Eyre, T. A. (2022) ‚ÄúPirtobrutinib results in reversible platelet dysfunction compared to ibrutinib and acalabrutinib‚ÄĚ, Haematologica. Pavia, Italy, 108(5), pp. 1429-1435. doi: 10.3324/haematol.2022.281402.